Chem Structure 1 (Memantine And Donepezil Hydrochlorides Extended Re 1)
Memantine And Donepezil Hydrochlorides Extended-release Capsule, Extended Release
Product Images NDC 69238-1553
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Memantine And Donepezil Hydrochlorides Extended-release (NDC 69238-1553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 8 (Memantine And Donepezil Hydrochlorides Extended Re 10)
This is a comparison of the effects of donepezil hydrochloride of 10mg/day versus Placebo on ADL (Activities of Daily Living) in patients. The graph shows the change from baseline over time (15 weeks) and the axes appear to be labeled in some undecipherable code.*
14mg Label (Memantine And Donepezil Hydrochlorides Extended Re 11)
This is a description of a drug called "Memantine and Donepezil Hydrochlorides Extended-release Capsules". Each capsule contains 7mg of memantine HCI and 10mg of donepezil HCI. The recommended dosage is 1 capsule per day. The package insert contains full Prescribing Information. It should be stored in a tight, light-resistant container, between 20° to 25°C (68° to 77°F), with excursions from 15° to 30°C (59° to 86°F) permitted. It's important to keep this and all drugs out of the reach of children. The drug is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
28mg Label (Memantine And Donepezil Hydrochlorides Extended Re 12)
This is a description for Memantine and Donepezil Hydrochlorides Extended-release Capsules with a strength of 14 mg/10 mg. The product is meant for prescription use only with 90 capsules in each container. The capsule contains 14 mg of memantine HCI, USP extended-release, and 10 mg of donepezil HCI, USP. Patients are advised to take 1 capsule once daily. The package insert contains the full prescribing information while the container should be stored in a tight, light-resistant container, as defined in the USP, and should be kept out of reach of children. The medication is distributed by Amneal Pharmaceuticals, Bridgewater, NJ 08807.*
Memantine And Donepezil Hydrochlorides Extended Re 13
Each capsule of NDC 69238-1553-9 contains 21mg of memantine HCI, USP and 10mg of donepezll HCI, USP. This medication is used to treat Alzheimer's disease. The usual dosage is to take one capsule once a day. The drug should be kept in a tight, light-resistant container and stored between 20°C to 25°C (68°F to 77°F). The medication is distributed by Amneal Pharmaceuticals LLC.*
Memantine And Donepezil Hydrochlorides Extended Re 14
This is a description of a medication with NDC 69235-1247-9 used to treat memory loss. It contains 28 mg of memanting HC, USP extended-release and 10 mg of donepezl HC, USP. The usual dosage is one capsule a day, and the prescription should be followed according to the package insert. The drug should be stored at a temperature between 20°C to 25°C and kept out of reach from children. The medication is distributed by Amneal Pharmaceuticals in Bridgevater, NJ 08807.*
Chem Structure 2 (Memantine And Donepezil Hydrochlorides Extended Re 2)
Figure 1 (Memantine And Donepezil Hydrochlorides Extended Re 3)
Figure 2 (Memantine And Donepezil Hydrochlorides Extended Re 4)
Figure 3 (Memantine And Donepezil Hydrochlorides Extended Re 5)
Figure 4 (Memantine And Donepezil Hydrochlorides Extended Re 6)
Figure 5 (Memantine And Donepezil Hydrochlorides Extended Re 7)
Figure 6 (Memantine And Donepezil Hydrochlorides Extended Re 8)
The text seems to be a list of two items, one of which mentions the use of "donepezil hydrochloride" at a dosage of "10 mg/day", while the other mentions "placebo". It is unclear what the set of numbers and characters at the end means.*
Figure 7 (Memantine And Donepezil Hydrochlorides Extended Re 9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
